Forest City Ratner Cos. announced Jan. 23 that Two Sigma Investments, a tech and investment firm, is the first company to be selected to locate at The Bridge at Cornell Tech.
A gene essential for making blood vessels in embryos can successfully transform amniotic cells into therapeutic blood vessel cells, according to new research from Weill Cornell Medicine.
Lewis C. Cantley and Kristy Richards are growing radically collaborative research connections between Weill Cornell Medicine and the College of Veterinary Medicine.
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
